Financial Architects (New Jersey)’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Financial Architects (New Jersey)’s Portfolio MRTX Stock Details MRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-100	Closed	-$5K	–	1529
2018 Q3	$5K	Buy	+100	New	+$5.57K	﹤0.01%	1237
2018 Q2	–	Sell	-1,400	Closed	-$43K	–	1550
2018 Q1	$43K	Buy	1,400 +350	+33%	+$9.72K	0.01%	655
2017 Q4	$19K	Hold	1,050	–	–	﹤0.01%	979
2017 Q3	$12K	Sell	1,050 -5,000	-83%	-$28.9K	﹤0.01%	1088
2017 Q2	$22K	Hold	6,050	–	–	﹤0.01%	936
2017 Q1	$31K	Hold	6,050	–	–	0.01%	812
2016 Q4	$29K	Hold	6,050	–	–	0.01%	738
2016 Q3	$40K	Hold	6,050	–	–	0.01%	645
2016 Q2	$33K	Buy	6,050 +1,050	+21%	+$16.7K	0.01%	648
2016 Q1	$107K	Buy	+5,000	New	+$112K	0.04%	264
2015 Q3	–	Sell	-5,000	Closed	-$157K	–	973
2015 Q2	$157K	Hold	5,000	–	–	0.06%	231
2015 Q1	$147K	Buy	5,000 +2,000	+67%	+$46.9K	0.06%	237
2014 Q4	$56K	Hold	3,000	–	–	0.02%	331
2014 Q3	$53K	Buy	+3,000	New	+$56K	0.03%	304

Other funds holding MRTX

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Financial Architects (New Jersey)'s MRTX Position: Q4 2018 in Review

Financial Architects (New Jersey) sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q4 2018, closing a stake of 100 shares — an estimated $5K sold.

Financial Architects (New Jersey) first reported a position in MRTX in Q3 2014 and held it in 14 quarters. The position peaked at $157K in Q2 2015. 112 funds tracked by Wall St. Rank hold MRTX as of Q4 2018.

Financial Architects (New Jersey) reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
Financial Architects (New Jersey) sold 100 Mirati Therapeutics, Inc. Common Stock shares in Q4 2018, an estimated $5K.
Financial Architects (New Jersey) first reported a position in Mirati Therapeutics, Inc. Common Stock in Q3 2014 and held it in 14 quarters.
Financial Architects (New Jersey)'s Mirati Therapeutics, Inc. Common Stock position peaked at $157K in Q2 2015.
112 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q4 2018.

Based on Financial Architects (New Jersey)'s 13F filing for Q4 2018, filed 1 Feb 2019.